X

Trial Profile

Comparison of the Effect of Insulin Detemir Versus Insulin NPH Both With Insulin Aspart on Weight Change in Overweight and Obese Subjects With Type 2 Diabetes

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 11 Apr 2022

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Insulin detemir (Primary) ; Insulin suspension isophane
Indications Type 2 diabetes mellitus
Focus Adverse reactions
Acronyms PREDICTIVE-BMI
Sponsors Novo Nordisk

Most Recent Events

03 Jul 2009 Actual end date (1 Dec 2006) added as reported by ClinicalTrials.gov.
08 Aug 2008 Results were published in Diabetic Medicine
18 Sep 2007 Status change

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com